Human Genome Epidemiology Literature Finder
Records 1 - 30 (of 422 Records) |
Query Trace: IDH2[original query] |
---|
Persistent IDH mutations are not associated with increased relapse or death in patients with IDH -mutated acute myeloid leukemia undergoing allogeneic hematopoietic cell transplant with post-transplant cyclophosphamide. medRxiv : the preprint server for health sciences 2023 9 . Niveditha Ravindra, Laura W Dillon, Gege Gui, Matthew Smith, Lukasz P Gondek, Richard J Jones, Adam Corner, Christopher S Hourigan, Alexander J Ambind |
Genetic Polymorphism Study of IDH 1/2 and TET2 Genes in Acute Myeloid leukemia Patients. Asian Pacific journal of cancer prevention : APJCP 2023 9 24 (9): 3169-3182. Manal Atef, Nevine Fawzy Shafik, Nagwa H A Hassan, Rasha Mahmoud Allam, Yomna Mohamed El-Meligui, Hisham Abdelaz |
IDH mutations in G2-3 conventional central bone chondrosarcoma: a mono institutional experience. BMC cancer 2023 9 23 (1): 907. Elisabetta Setola, S Benini, A Righi, G Gamberi, E Carretta, C Ferrari, S Avnet, E Palmerini, G Magagnoli, M Gambarotti, P L Lollini, M Cesari, S Cocchi, A Paioli, A Longhi, K Scotlandi, M A Laginestra, D M Donati, N Baldini, T Ibrah |
Clinico-genomic profiling of conventional and dedifferentiated chondrosarcomas reveals TP53 mutation to be associated with worse outcomes. Clinical cancer research : an official journal of the American Association for Cancer Research 2023 9 . Ryan A Denu, Richard K Yang, Alexander J Lazar, Shalin S Patel, Valerae O Lewis, Jason Roszik, J Andrew Livingston, Wei-Lien Wang, Kenna R Shaw, Ravin Ratan, Maria A Zarzour, Justin Bird, Shaan M Raza, Kadir C Akdemir, Jordi Rodon Ahnert, Vivek Subbiah, Shreyaskumar Patel, Anthony P Conl |
Perturbed epigenetic transcriptional regulation in AML with IDH mutations causes increased susceptibility to NK cells. Leukemia 2023 7 . Anna Palau, Filip Segerberg, Michael Lidschreiber, Katja Lidschreiber, Aonghus J Naughton, Maria Needhamsen, Lisa Anna Jung, Maja Jagodic, Patrick Cramer, Sören Lehmann, Mattias Carlsten, Andreas Lennartss |
The impact of IDH and NAT2 gene polymorphisms in acute myeloid leukemia risk and overall survival in an Arab population: A case-control study. PloS one 2023 7 18 (7): e0289014. Sohaib M Al-Khatib, Obada Ababneh, Hassann Abushukair, Nour Abdo, Laith N Al-Eit |
Novel RUNX1 Variation in B-cell Acute Lymphoblastic Leukemia. Mediterranean journal of hematology and infectious diseases 2023 7 15 (1): e2023036. Egzona Qipa, Muradiye Acar, Sureyya Bozkurt, Murat Buyukdogan, Hazal B Sonmez, Muge Sayitoglu, Yucel Erbilgin, Zeynep Karaka?, Veysel S Hanç |
Identification of prognostic and driver gene mutations in acute myeloid leukemia by a bioinformatics analysis. Translational cancer research 2023 7 12 (6): 1552-1564. Lifang Li, Jingxiong Ruan, Ning Zhang, Jia Dai, Xin Xu, Xudong Tian, Jian |
Prognostic value of IDH2R140 and IDH2R172 mutations in patients with acute myeloid leukemia: a systematic review and meta-analysis. BMC cancer 2023 6 23 (1): 527. Yao Qin, Kai Shen, Ting Liu, Hongbing |
Polymorphism in epigenetic regulating genes in relation to periodontitis, number of teeth, and levels of high-sensitivity C-reactive protein and glycated hemoglobin: The Tromsø Study 2015-2016. Journal of periodontology 2023 6 . Farah Asa'ad, Natalia Petrenya, Birgitta Jönsson, Gro Eirin Holde, Nils Oscarson, Elin Hadler-Olsen, Alexandre R Vieira, Max Petzold, Lena Larss |
Clinical and prognostic profile of SRSF2 and related spliceosome mutations in patients with acute myeloid leukemia. Molecular biology reports 2023 6 . Wenbo Jia, Xiaodong Guo, Yihong Wei, Jinting Liu, Can Can, Ruiqing Wang, Xinyu Yang, Chunyan Ji, Daoxin |
Isocitrate Dehydrogenase 1 and 2 Mutations in Pediatric Neuroblastoma Patients. Medeniyet medical journal 2023 6 38 (2): 102-110. Emre Leventoglu, Gurses Sahin, Sule Yesil, Ceyhun Bozkurt, Nazmiye Yuksek, Ali Fettah, Sule Toprak, Burcak Kurucu Bilgin, Emre Capkinoglu, Nilgun Eroglu, Sibel Akpinar Tekgunduz, Ayse Ulya Ert |
Characteristics and prognostic impact of IDH mutations in AML: a COG, SWOG, ECOG analysis. Blood advances 2023 6 . Sara Zarnegar-Lumley, Todd Alonzo, Robert B Gerbing, Megan Othus, Zhuoxin Sun, Rhonda E Ries, Jim Wang, Amanda R Leonti, Matthew A Kutny, Fabiana Ostronoff, Jerald P Radich, Frederick R Appelbaum, Era L Pogosova-Agadjanyan, Kristen M O'Dwyer, Martin S Tallman, Mark R Litzow, Ehab Atallah, Todd M Cooper, Richard Aplenc, Omar I Abdel-Wahab, Alan S Gamis, Selina M Luger, Harry P Erba, Ross L Levine, E Anders Kolb, Derek L Stirewalt, Soheil Meshinchi, Katherine Tarlo |
Clinical and molecular characteristics of acute myeloid leukemia and the dismal prognosis of TP53 mutations in a real-world setting. Hematology (Amsterdam, Netherlands) 2023 6 28 (1): 2223866. Hong Liu, Yuye Shi, Shandong Tao, Yunjie Li, Chunling Wang, Liang |
Relationship between IDH1/2 and TERT promoter mutation and the prognosis of human glioma patients. Pakistan journal of medical sciences 2023 5 39 (3): 843-847. Xipeng Liu, Ming Liu, Bing Cao, Jianxin Qiao, Xiufeng Zha |
DNA Sequencing to Detect Residual Disease in Adults With Acute Myeloid Leukemia Prior to Hematopoietic Cell Transplant. JAMA 2023 3 329 (9): 745-755. Dillon Laura W, Gui Gege, Page Kristin M, Ravindra Niveditha, Wong Zoë C, Andrew Georgia, Mukherjee Devdeep, Zeger Scott L, El Chaer Firas, Spellman Stephen, Howard Alan, Chen Karen, Auletta Jeffery, Devine Steven M, Jimenez Jimenez Antonio Martin, De Lima Marcos J G, Litzow Mark R, Kebriaei Partow, Saber Wael, Weisdorf Daniel J, Hourigan Christopher |
Clinical characteristics and prognostic significance of DNA methylation regulatory gene mutations in acute myeloid leukemia. Clinical epigenetics 2023 3 15 (1): 54. Xu Xiaoyan, Wang Hong, Han Haohao, Yao Yifang, Li Xueqian, Qi Jiaqian, Cai Chengsen, Zhou Meng, Tang Yaqiong, Pan Tingting, Zhang Ziyan, Yang Jingyi, Wu Depei, Han Y |
[Analysis of epigenetic modification gene mutations among patients with acute myeloid leukemia]. Zhonghua yi xue yi chuan xue za zhi = Zhonghua yixue yichuanxue zazhi = Chinese journal of medical genetics 2023 3 40 (4): 435-441. Wei Jifeng, Qiu Huiying, Zhou Hang, Chen Zhe, Miao Lei, Wang Ying, Zhao Lidong, Cai Zhim |
Multicenter Phase II Trial of the PARP Inhibitor Olaparib in Recurrent IDH1- and IDH2-mutant Glioma. Cancer research communications 2023 3 3 (2): 192-201. Fanucci Kristina, Pilat Mary Jo, Shyr Derek, Shyr Yu, Boerner Scott, Li Jing, Durecki Diane, Drappatz Jan, Puduvalli Vinay, Lieberman Frank Scott, Gonzalez Javier, Giglio Pierre, Ivy S Percy, Bindra Ranjit S, Omuro Antonio, LoRusso Patric |
Interplay between chronic inflammation and clonal haematopoiesis of indeterminate potential in Behçet's disease. Arthritis research & therapy 2023 3 25 (1): 33. Park Jihye, An Hongyul, Lim Jiwoo, Park I Seul, Kim Mi Hyun, Kim Ji Hyung, Kim Seung Won, Koh Young Il, Lee Eun Young, Cheon Jae H |
Distinct IDH1/2-associated Methylation Profile and Enrichment of TP53 and TERT Mutations Distinguish Dedifferentiated Chondrosarcoma from Conventional Chondrosarcoma. Cancer research communications 2023 3 3 (3): 431-443. Dermawan Josephine Kam Tai, Nafa Khedoujia, Mohanty Abhinita, Xu Yingjuan, Rijo Ivelise, Casanova Jacklyn, Villafania Liliana, Benhamida Jamal, Kelly Ciara M, Tap William D, Boland Patrick J, Fabbri Nicola, Healey John H, Ladanyi Marc, Lu Chao, Hameed Mee |
The impact of DNMT3A variant allele frequency and two different comutations on patients with de novo cytogenetically normal acute myeloid leukemia. Cancer medicine 2023 3 . Chen Xian, Tian Chuchu, Hao Zhuanghui, Pan Lingang, Hong Minglin, Wei Wei, Muyey Daniel Muteb, Wang Hongwei, Chen Xiuh |
[Effect of clonal hematopoiesis in remission on hematopoiesis recovery in patients with NPM1 mutated acute myeloid leukemia after chemotherapy]. Zhonghua xue ye xue za zhi = Zhonghua xueyexue zazhi 2023 12 44 (10): 845-850. L L Wang, S N Ch |
Polymorphism of salivary proteins and risk of periodontal diseases: A systematic review and meta-analysis of clinical studies. Journal of dentistry 2023 12 141 104804. Paras Ahmad, Walter Luiz Siquei |
Venetoclax and hypomethylating agent combination therapy in newly diagnosed acute myeloid leukemia: Genotype signatures for response and survival among 301 consecutive patients. American journal of hematology 2023 12 . Naseema Gangat, Omer Karrar, Moazah Iftikhar, Kristen McCullough, Isla M Johnson, Maymona Abdelmagid, Mostafa Abdallah, Aref Al-Kali, Hassan B Alkhateeb, Kebede H Begna, Abhishek Mangaonkar, Antoine N Saliba, Mehrdad Hefazi Torghabeh, Mark R Litzow, William Hogan, Mithun Shah, Mrinal M Patnaik, Animesh Pardanani, Talha Badar, Hemant Murthy, James Foran, Jeanne Palmer, Lisa Sproat, Nandita Khera, Cecilia Arana Yi, Ayalew Teffe |
Mutation analysis of the TERT gene in ovarian cancer patients of the Turkish population by next generation sequencing method. Cellular and molecular biology (Noisy-le-Grand, France) 2023 11 69 (11): 51-55. Betul Capar Gorali, Seda Gulec Y?lmaz, Fatma Tuba Akdeniz, Rukset Attar, Turgay ?sb |
Genomic Mutation Profiles of Patients with Acute Myeloid Leukemia in Korea: a Single-Center Experience. Clinical laboratory 2023 11 69 (11): . Eunhee Han, Soorack Ryu, Dohyang Kim, Eun-Ha Koh, Jung-Hyun Byun, Dong-Hyun L |
Somatic gene mutation patterns and burden influence outcomes with enasidenib in relapsed/refractory IDH2-mutated AML. Leukemia research 2024 4 140 107497. Alberto Risueño, Wendy L See, Iryna Bluemmert, Stéphane de Botton, Courtney D DiNardo, Amir T Fathi, Andre C Schuh, Pau Montesinos, Paresh Vyas, Thomas Prebet, Anita Gandhi, Maroof Has |
A nomogram based on clinical features and molecular abnormalities for predicting the prognosis of patients with acute myeloid leukemia. Translational cancer research 2024 1 12 (12): 3432-3442. Yuancheng Guo, Yujie Niu, Haiping Liang, Xiaoxiao Yang, Jinli Jian, Xiao Tang, Bei L |
[Mutation characteristics of angioimmunoblastic T-cell lymphoma: an analysis of 75 cases]. Zhonghua bing li xue za zhi = Chinese journal of pathology 2024 1 53 (1): 29-33. X Shen, H M Yi, A Q Li, B S Ouyang, L Dong, C F Wa |
- Page last reviewed:Feb 1, 2024
- Page last updated:Apr 22, 2024
- Content source: